معرفی
Prof. Rainer Lehmann serves as Principal Investigator at the Helmholtz Diabetes Center within the German Center for Diabetes Research (DZD), holding a professorship in the Faculty of Medicine at the University of Tübingen. He directs the Clinical Chemistry Lab, focusing on translational research in metabolic disorders through advanced biochemical analytics.
His research program centers on diabetes pathophysiology and metabolic disease mechanisms, utilizing cutting-edge metabolomics and lipidomics to identify diagnostic biomarkers and therapeutic targets. Key investigations explore bariatric surgery outcomes, exercise-induced metabolic adaptations, and sex-specific diagnostic patterns in prediabetes, emphasizing personalized intervention strategies for at-risk populations.
Analysis of his 2021-2025 publications reveals consistent leadership in multicenter studies examining metabolic surgery benefits, urine-based biomarker discovery, and mitochondrial adaptations to lifestyle interventions. His work demonstrates strong collaboration across the DZD network, particularly in elucidating subphenotype-specific responses to diabetes prevention strategies.
As head of the Clinical Chemistry Lab, Lehmann drives innovation in preanalytical sample handling and metabolite profiling, contributing to standardized protocols for clinical lipidomics and metabolomics research within the German diabetes research community.
